Georgia Center for Oncology Research and Education, Inc.
Advancing Cancer Care through Partnerships and Innovation
Georgia Center for Oncology Research and Education, Inc.
EIN: 57-1159979
as of September 2024
as of September 09, 2024
Programs and results
Reports and documents
Download annual reports Download other documentsWhat we aim to solve
Georgia CORE's mission is to advance cancer care through partnerships and innovation. We unite oncologists, public health professionals, researchers and educators in a dynamic collaboration to deliver Clinical research trials with the latest and most promising cancer treatments Screening to detect cancers at early stages when most treatable and potentially curable Genetic services to manage hereditary cancer risk and extend personalized cancer treatment Education and resources to improve quality of life for cancer survivors Advocacy to stimulate impactful investments in cancer among elected officials Georgia CORE is dedicated to improving cancer outcomes and equity of cancer care by serving racial and ethnic minorities and under-resourced communities.
Our programs
What are the organization's current programs, how do they measure success, and who do the programs serve?
Clinical Trials and Cancer Research
Georgia CORE's focus on increasing access to clinical trials has contributed to an eight-fold expansion in clinical trials and growth of community research across Georgia. The organization facilitates an award winning research network among leading community cancer centers with funding from the National Cancer Institute. 100 oncologists access dozens of clinical trials from 6 regional hubs. Enrollment of racial and ethnic minorities is 25% - 6 times the national average. Enrollment of rural patients is 18% - there are no national benchmarks available. Georgia CORE also participates in cancer care delivery research and comparative effectiveness research.
Breast Cancer Screening & Genetic Risk Assessment
Georgia CORE raises funds for breast cancer screening via sale of the state's breast cancer license tag. The focus is on increasing access to mammography, breast exams and genetic screening among women with greater cancer incidence and mortality rates; 85% of clients are racial or ethnic minorities. In partnership with the State Office of Rural Health over $3.5 million has been granted to 26 community partners for this program. In collaboration with the Georgia Department of Public Health Georgia CORE provides genetic risk assessment, testing and counseling for Hereditary Breast and Ovarian Cancer in 14 health districts. 51% of clients are racial or ethnic minorities. On line risk assessment and resources are available through Georgia CORE's website BreastCancerGeneScreen.org.
Where we work
Our results
How does this organization measure their results? It's a hard question but an important one.
Evaluation documents
Download evaluation reportsPatients on Clinical Trials through Georgia National Cancer Institute funded Community Oncology Research Program
This metric is no longer tracked.Totals By Year
Population(s) Served
People with diseases and illnesses, Ethnic and racial groups, Adults, Economically disadvantaged people, People with disabilities
Related Program
Clinical Trials and Cancer Research
Type of Metric
Outcome - describing the effects on people or issues
Direction of Success
Decreasing
Context Notes
The Georgia NCORP is 1 of 34 organizations in the nation that provides access to the latest NCI cancer clinical trials to patients in their communities. The numbers indicate the program winding down
Number of genetic risk assessments for Hereditary Breast and Ovarian Cancer via BreastCancerGeneScreen.org
This metric is no longer tracked.Totals By Year
Population(s) Served
Ethnic and racial groups, Social and economic status, Young adults, Pregnant people
Related Program
Breast Cancer Screening & Genetic Risk Assessment
Type of Metric
Output - describing our activities and reach
Direction of Success
Increasing
Context Notes
Women screened in public and community health clinics receive genetic testing, counseling and education prior to a diagnosis of cancer
Number of Visitors Seeking Cancer Information & Resources via GeorgiaCancerInfo.org
This metric is no longer tracked.Totals By Year
Type of Metric
Output - describing our activities and reach
Direction of Success
Increasing
Percentage of participants in clinical cancer research by race and ethnicity
This metric is no longer tracked.Totals By Year
Population(s) Served
Ethnic and racial groups, Chronically ill people, Terminally ill people
Related Program
Clinical Trials and Cancer Research
Type of Metric
Output - describing our activities and reach
Direction of Success
Holding steady
Context Notes
Nationally less than 4% of minorities with cancer participate in clinical research. In Georgia NCORP 6 times more minorities receive the latest and most promising cancer treatments.
Goals & Strategy
Learn about the organization's key goals, strategies, capabilities, and progress.
Charting impact
Four powerful questions that require reflection about what really matters - results.
What is the organization aiming to accomplish?
To improve health and quality of life outcomes for patients and survivors by decreasing or eliminating disparities in cancer care. These goals are accomplished through
Collaboration -- delivering high quality programs and services through innovative partnerships and with measurable outcomes
Access -- serving those in areas of greatest need and opportunity to improve cancer prevention, screening and treatment
Equity -- engaging racial and ethnic minorities and survivors at all levels of the organization
Advocacy -- advocating for policies, programs and funding that are evidence-based and address identified needs
Creating statewide access to equitable, inclusive cancer care , research and resources
Expanding the reach of clinical trials and new cancer treatments through personalized medicine
Establishing and funding cancer screening initiatives
Developing and offering education, programs and services focused on survivors
Introducing genetic screening, testing and counseling in public health settings
Providing cancer policy briefings to guide informed investments by lawmakers and public officials
Engaging stakeholders in the development and monitoring of the Georgia Cancer Plan
Disseminating research and outcomes through conferences, whitepapers and peer-reviewed publications
Collaboration -- delivering high quality programs and services through innovative partnerships and with measurable outcomes
Access -- serving those in areas of greatest need and opportunity to improve cancer prevention, screening and treatment
Equity -- engaging racial and ethnic minorities and survivors at all levels of the organization
Advocacy -- advocating for policies, programs and funding that are evidence-based and address identified needs
What are the organization's key strategies for making this happen?
Facilitating a collaborative community research network for the conduct of cancer clinical trials and cancer care delivery research with funding from the National Cancer Institute;
Expanding screening, treatment, navigation, survivorship and genetics services for high risk and underserved women through a network of public and private partners;
Analyzing the health and economic impact of the state's investments of tobacco settlement funds for cancer;
Providing policy briefings to lawmakers to guide informed investments in cancer care and research;
Creating and sustaining statewide partnerships to develop, implement and track outcomes of the Georgia Cancer Plan;
Providing navigation services and resources to patients, caregivers, survivors and cancer professionals;
Disseminating research and resources through websites, professional conferences, whitepapers and publications;
Providing exceptional management and governance.
What are the organization's capabilities for doing this?
Georgia CORE is a public-private partnership that unites experts, survivors, healthcare and cancer-fighting organizations into a single force -- to provide higher quality of care for patients and better quality of life for survivors throughout Georgia. The organization's capabilities are defined by the following assets and resources:
*Board of Directors of multi-disciplinary cancer experts and thought leaders
*Diverse and highly qualified staff; engaged team of volunteers and survivors
*Research network of academic, community and public health centers reaching all corners of the state
*GeorgiaCancerInfo.org a comprehensive online cancer information center and BreastCancerGeneScreen.org for genetic resources and on line genetic risk assessment
*Cancer Survivorship Connection led by an Advisory Board of cancer survivors
*Extensive partnerships among academic and community cancer centers, public health and non profit organizations
*Co-sponsorship of Cancer Patient Navigators of Georgia with the Georgia Society of Clinical Oncology (GASCO) to extend training and support to navigators and caregivers
*Individual contributors, volunteers and community health organizations engaged in supporting breast cancer screening and cancer research.
* Resilience and sustainability driven by strong management and funding from government grants, research contracts and private contributions
What have they accomplished so far and what's next?
Georgia CORE was created fifteen years ago to address the state's disparity in clinical trials and ensure access to the latest research advances so that Georgians could receive the best cancer care close to home. Today Georgia has a reputation as a premier destination for cancer care. Georgia CORE adds to the state’s distinction as a national leader in numerous ways. The results of our programs document an increase in clinical trials accrual in community centers; expansion of clinical trials into rural communities; and reduction of racial and ethnic disparities in research and screening. Georgia CORE’s websites GeorgiaCancerInfo.org and BreastCancerGeneScreen.org fill a critical need for a coordinated and centralized platform that allows patients, caregivers and survivors access to information and resources. Innovative genetic risk assessment, counseling and testing are delivered in public health centers across the state. Legislative advocacy provided by Georgia CORE has contributed to enhancements in state funding for numerous cancer programs. Multiple peer reviewed publications co-authored by Georgia CORE’s staff and partners document these outcomes while recognition from the National Cancer Institute affirms the high level of performance of our research network. All this is accomplished through a unique, cost effective model and there is no other program in the nation quite like ours.
Georgia CORE is evolving in response to dynamic changes in the art and science of oncology care, remaining true to our founding principles, undergoing strategic planning and preparing for long term sustainability. The state’s leading experts in oncology consistently serve on Georgia CORE’s Board of Directors. Their leadership transcends competition to create the culture of cancer collaboration that distinguishes Georgia and makes it possible to develop and nurture a broad consortium of partners -- academic medical centers, community cancer programs, regional cancer coalitions and cancer non-profits. The Board and executive staff have enhanced organizational financial performance by attracting and retaining a talented staff; holding down administrative costs; balancing public and private funding; reducing expenses via a contract with Georgia State University for human resources, payroll and benefits; creating funds for organizational sustainability and future strategic initiatives.
Financials
Financial documents
Download audited financialsRevenue vs. expenses: breakdown
Liquidity in 2023 info
2.39
Months of cash in 2023 info
5.4
Fringe rate in 2023 info
0%
Funding sources info
Assets & liabilities info
Financial data
Georgia Center for Oncology Research and Education, Inc.
Revenue & expensesFiscal Year: Jul 01 - Jun 30
Georgia Center for Oncology Research and Education, Inc.
Balance sheetFiscal Year: Jul 01 - Jun 30
The balance sheet gives a snapshot of the financial health of an organization at a particular point in time. An organization's total assets should generally exceed its total liabilities, or it cannot survive long, but the types of assets and liabilities must also be considered. For instance, an organization's current assets (cash, receivables, securities, etc.) should be sufficient to cover its current liabilities (payables, deferred revenue, current year loan, and note payments). Otherwise, the organization may face solvency problems. On the other hand, an organization whose cash and equivalents greatly exceed its current liabilities might not be putting its money to best use.
Georgia Center for Oncology Research and Education, Inc.
Financial trends analysis Glossary & formula definitionsFiscal Year: Jul 01 - Jun 30
This snapshot of Georgia Center for Oncology Research and Education, Inc.’s financial trends applies Nonprofit Finance Fund® analysis to data hosted by GuideStar. While it highlights the data that matter most, remember that context is key – numbers only tell part of any story.
Created in partnership with
Business model indicators
Profitability info | 2018 | 2019 | 2020 | 2021 | 2023 |
---|---|---|---|---|---|
Unrestricted surplus (deficit) before depreciation | $343,317 | $397,743 | $298,149 | $28,592 | $566,719 |
As % of expenses | 22.5% | 19.6% | 15.7% | 2.3% | 17.0% |
Unrestricted surplus (deficit) after depreciation | $332,438 | $363,761 | $232,295 | -$18,055 | $545,841 |
As % of expenses | 21.6% | 17.7% | 11.9% | -1.4% | 16.3% |
Revenue composition info | |||||
---|---|---|---|---|---|
Total revenue (unrestricted & restricted) | $1,856,297 | $2,317,460 | $2,119,383 | $1,268,189 | $3,851,499 |
Total revenue, % change over prior year | 0.7% | 24.8% | -8.5% | -40.2% | 0.0% |
Program services revenue | 11.3% | 17.2% | 15.2% | 0.0% | 0.0% |
Membership dues | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Investment income | 0.1% | 0.1% | 0.0% | 0.0% | 0.0% |
Government grants | 88.6% | 66.5% | 72.6% | 93.7% | 88.0% |
All other grants and contributions | 0.0% | 16.2% | 12.1% | 6.3% | 11.9% |
Other revenue | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% |
Expense composition info | |||||
---|---|---|---|---|---|
Total expenses before depreciation | $1,526,221 | $2,024,500 | $1,893,234 | $1,239,947 | $3,329,137 |
Total expenses, % change over prior year | -12.2% | 32.6% | -6.5% | -34.5% | 0.0% |
Personnel | 45.0% | 43.1% | 47.2% | 23.1% | 37.7% |
Professional fees | 12.0% | 10.1% | 11.0% | 25.6% | 5.2% |
Occupancy | 2.2% | 1.8% | 1.9% | 2.0% | 2.5% |
Interest | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Pass-through | 19.7% | 21.6% | 25.2% | 36.8% | 47.7% |
All other expenses | 21.1% | 23.5% | 14.7% | 12.5% | 6.9% |
Full cost components (estimated) info | 2018 | 2019 | 2020 | 2021 | 2023 |
---|---|---|---|---|---|
Total expenses (after depreciation) | $1,537,100 | $2,058,482 | $1,959,088 | $1,286,594 | $3,350,015 |
One month of savings | $127,185 | $168,708 | $157,770 | $103,329 | $277,428 |
Debt principal payment | $0 | $0 | $0 | $0 | $0 |
Fixed asset additions | $0 | $107,597 | $0 | $47,453 | $0 |
Total full costs (estimated) | $1,664,285 | $2,334,787 | $2,116,858 | $1,437,376 | $3,627,443 |
Capital structure indicators
Liquidity info | 2018 | 2019 | 2020 | 2021 | 2023 |
---|---|---|---|---|---|
Months of cash | 4.6 | 4.8 | 7.7 | 10.9 | 5.4 |
Months of cash and investments | 4.6 | 4.8 | 7.7 | 10.9 | 5.4 |
Months of estimated liquid unrestricted net assets | 4.4 | 5.1 | 8.1 | 12.2 | 7.5 |
Balance sheet composition info | 2018 | 2019 | 2020 | 2021 | 2023 |
---|---|---|---|---|---|
Cash | $580,801 | $811,248 | $1,210,041 | $1,121,785 | $1,504,853 |
Investments | $0 | $0 | $0 | $0 | $0 |
Receivables | $571,255 | $790,442 | $667,606 | $533,114 | $1,169,903 |
Gross land, buildings, equipment (LBE) | $77,806 | $185,403 | $64,954 | $55,963 | $12,610 |
Accumulated depreciation (as a % of LBE) | 74.6% | 49.6% | 91.6% | 88.8% | 84.2% |
Liabilities (as a % of assets) | 34.8% | 39.1% | 33.6% | 24.2% | 23.2% |
Unrestricted net assets | $585,053 | $948,814 | $1,284,652 | $1,266,597 | $2,080,869 |
Temporarily restricted net assets | $199,123 | N/A | N/A | N/A | N/A |
Permanently restricted net assets | $0 | N/A | N/A | N/A | N/A |
Total restricted net assets | $199,123 | $94,340 | $44,357 | $44,357 | $0 |
Total net assets | $784,176 | $1,043,154 | $1,329,009 | $1,310,954 | $2,080,869 |
Key data checks
Key data checks info | 2018 | 2019 | 2020 | 2021 | 2023 |
---|---|---|---|---|---|
Material data errors | No | No | No | No | No |
Operations
The people, governance practices, and partners that make the organization tick.
Documents
President & CEO
Lynn Durham
With a 25-year career in university administration and management, Lynn is a former Georgia CORE director and volunteer and three-time cancer survivor. Lynn works with partners and the board of directors to lead the organization’s efforts to improve access to clinical trials, as well as personalized cancer care and support for patients, survivors, and caregivers. She also conducts critical outreach on behalf of the organization to state legislators and officials.
Lynn spent the majority of her career in higher education administration at Georgia Tech, where she served as associate vice president and chief of staff to President Bud Peterson and later as vice president for Institute Relations. She holds a Doctor of Education degree from the University of Georgia, a master’s degree in Public Administration from Kennesaw State University, and a bachelor’s degree from Radford University in Radford, Virginia.
Vice President
Kristina Forbes
Kristina is passionate about community engagement and service, dedicating her time out of the office towards promoting STEAM opportunities, entrepreneurship, innovation, and youth development. As Georgia CORE’s Vice President for Administration, she will leverage her experience driving organizational growth to impact mission and vision and her significant expertise in operations, events, grant management, fundraising, and human resources.
Prior to her current role, Kristina was the Vice President of Operations for the Center for Global Health Innovation, where she created policies and oversaw operations and all revenue generating activities. She also served in business development and fundraising roles for the Technology Association of Georgia, Chi Phi Educational Trust, and the Boy Scouts of America. Kristina graduated from the University of Georgia with a Bachelor of Science in Psychology.
Number of employees
Source: IRS Form 990
Georgia Center for Oncology Research and Education, Inc.
Officers, directors, trustees, and key employeesSOURCE: IRS Form 990
Compensation data
Georgia Center for Oncology Research and Education, Inc.
Highest paid employeesSOURCE: IRS Form 990
Compensation data
Georgia Center for Oncology Research and Education, Inc.
Board of directorsas of 11/03/2023
Board of directors data
Dr. Andrew Pippas
Piedmont Columbus Regional
Term: 2016 - 2024
Dr. Roland Matthews
Morehouse School of Medicine
Term: 2010 - 2026
Andrew W. Pippas
Piedmont Columbus Regional
Roland Matthews
Morehouse School of Medicine
Frederick M. Schnell
Community Oncology Alliance
Charles H. Nash
Northeast Georgia Medical Center
Sharad A. Ghamande
Georgia Cancer Center, Augusta University
Harvey James Hamrick
Flatiron Health
Amelia A Langston
Winship Cancer Institute, Emory University
Craig Smith
McDermott, Will & Emery
Jorge Cortes
Georgia Cancer Center, Augusta University
Jamie Hodgson
University Cancer and Blood Center
Steven W. McLaughlin
Georgia Institute of Technology
Matt Mumber
Harbin Clinic
Nancy Paris
Suresh Ramalingam
Winship Cancer Institute, Emory University
Stephanie Smith Reyes
Lewis Cancer & Research Pavillion, St. Joseph's/Candler Hospital
Board leadership practices
GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section.
-
Board orientation and education
Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations? Yes -
CEO oversight
Has the board conducted a formal, written assessment of the chief executive within the past year ? Yes -
Ethics and transparency
Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements in the past year? Yes -
Board composition
Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership? Yes -
Board performance
Has the board conducted a formal, written self-assessment of its performance within the past three years? Yes
Organizational demographics
Who works and leads organizations that serve our diverse communities? Candid partnered with CHANGE Philanthropy on this demographic section.
Leadership
The organization's leader identifies as:
The organization's co-leader identifies as: